Genentech’s Next Move

Genentech’s Next Move Genentech stunned the cancer world last week with news that its Avastin colon cancer drug extended patients’ lives by five months, proving wrong skeptics who said the blood vessel-blocking drug would never work. Now the biotech pioneer is embarking on a bold strategy to dominate the cancer drug market for decades to […]

Get email updates

Get new actionable insights and updates from BiotechBlog